Literature DB >> 15361507

Pharmacology of serotonin: what a clinician should know.

F De Ponti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15361507      PMCID： PMC1774227          DOI： 10.1136/gut.2003.035568

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  181 in total

Review 1.  Neurotransmitters in neuronal reflexes regulating intestinal secretion.

Authors:  H J Cooke
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

Authors:  V ERSPAMER; B ASERO
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

3.  Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects.

Authors:  B Coffin; J-P Farmachidi; P Rueegg; A Bastie; D Bouhassira
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

4.  D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells.

Authors:  M Kim; H J Cooke; N H Javed; H V Carey; F Christofi; H E Raybould
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

5.  Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter.

Authors:  Min-Tsai Liu; Stephen Rayport; Yan Jiang; Dennis L Murphy; Michael D Gershon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09-04       Impact factor: 4.052

6.  Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects.

Authors:  D Sifrim; R H Holloway; J Tack; A Zelter; T Missotten; B Coulie; J Janssens
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

Review 7.  Cilansetron. Solvay.

Authors:  G Stacher
Journal:  Curr Opin Investig Drugs       Date:  2001-10

8.  Central modulation of rectal distension-induced blood pressure changes by alosetron, a 5-HT3 receptor antagonist.

Authors:  M Miura; D C Lawson; E M Clary; A W Mangel; T N Pappas
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

9.  An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.

Authors:  J Kellow; O Y Lee; F Y Chang; S Thongsawat; M Z Mazlam; H Yuen; K A Gwee; Y T Bak; J Jones; A Wagner
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

10.  5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine.

Authors:  J R Grider; A E Foxx-Orenstein; J G Jin
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682
View more
  36 in total

1.  Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion.

Authors:  Jermaine D Jones; F Scott Hall; George R Uhl; Kenner Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2009-04-17       Impact factor: 3.533

2.  5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine.

Authors:  Pawan Kumar Shahi; Seok Choi; Dong Chuan Zuo; Cheol Ho Yeum; Pyung Jin Yoon; Jun Lee; Young Dae Kim; Chan Guk Park; Man Yoo Kim; Hye Rang Shin; Hyun Jung Oh; Jae Yeoul Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-06-30       Impact factor: 2.016

Review 3.  Mindful Eating: A Review Of How The Stress-Digestion-Mindfulness Triad May Modulate And Improve Gastrointestinal And Digestive Function.

Authors:  Christine E Cherpak
Journal:  Integr Med (Encinitas)       Date:  2019-08

4.  Idiopathic Dyspepsia.

Authors:  Vincenzo Stanghellini; Elisabetta Poluzzi; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Roberto Corinaldesi
Journal:  Curr Treat Options Gastroenterol       Date:  2005-04

5.  Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.

Authors:  Susanna Every-Palmer; Stephen J Inns; Eve Grant; Pete M Ellis
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

6.  Prucalopride: the evidence for its use in the treatment of chronic constipation.

Authors:  Georges Coremans
Journal:  Core Evid       Date:  2008-06

7.  Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats.

Authors:  Evelin Painsipp; Anaid Shahbazian; Peter Holzer
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

8.  Effects of ondansetron on gastric tone and motility changes induced by a prolonged intraduodenal infusion of nutrients. Results of a placebo-controlled study.

Authors:  Guillaume Savoye; Maud Brung-Lefebvre; Mickael Bouin; Céline Maillot; Philippe Denis; Philippe Ducrotté
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

Review 9.  Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.

Authors:  Lekha Saha
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

10.  The 5-HT4 Receptor Agonist Prucalopride Stimulates Mucosal Growth and Enhances Carbohydrate Absorption in the Ileum of the Mouse.

Authors:  Christine J Park; Sarah J Armenia; Lucy Zhang; Robert A Cowles
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.